Literature DB >> 35271917

Co-administration of treatment for rifampicin-resistant TB and chronic HCV infection: A TBnet and ESGMYC study.

Simone Tunesi1, Damien Le Dû2, Gina Gualano3, Joan-Pau Millet4, Aliaksandr Skrahin5, Graham Bothamley6, Xavier Casas7, Delia Goletti3, Christoph Lange8, Maria Musso3, Fabrizio Palmieri3, Valérie Pourcher9, Christophe Rioux10, Alena Skrahina5, Nicolas Veziris11, Dzmitry Viatushka5, Mathilde Jachym-Fréchet2, Lorenzo Guglielmetti12.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2022        PMID： 35271917     DOI： 10.1016/j.jinf.2022.03.004

Source DB:  PubMed          Journal:  J Infect        ISSN： 0163-4453            Impact factor:   6.072


× No keyword cloud information.
  1 in total

1.  Integrating hepatitis C treatment into multidrug-resistant TB care.

Authors:  O Kirakosyan; N Melikyan; J Falcao; N Khachatryan; H Atshemyan; I Oganezova; A Aznauryan; L Yeghiazaryan; N Sargsyants; A Hayrapetyan; S Balkan; C Hewison; H Huerga
Journal:  Public Health Action       Date:  2022-06-21
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.